InvestorsHub Logo
Followers 133
Posts 3293
Boards Moderated 0
Alias Born 06/22/2018

Re: None

Monday, 06/06/2022 4:30:36 PM

Monday, June 06, 2022 4:30:36 PM

Post# of 704933
Just received this email from the company!! Looks like we're expanding getting ready fo approval in the UK and $4.8 billion in annual revenue.!!!

Cheers,

BB



4800 Montgomery Lane
Suite 800
Bethesda, MD 20814
t (240) 497-9024 ____www.nwbio.com
f (240) 497-4065____OTCQB: NWBO

June 6, 2022

?
Dear Emerald,

We are pleased to send you our most recent release announcing Dr. Marnix Bosch’s presentation in Chicago on Saturday, June 4, 2022. This presentation included, among other initiatives, DCVax-L technology, progress on automation, and plans for manufacturing scale-up.

Dr. Bosch also announced that additional information about the DCVax-L clinical program was being screened at the Company’s booth in the exhibit hall.

The release concludes by indicating you can find both these presentations at the following link: https://virtualtrials.org/dcvax



Best,


Dave Innes
VP, Investor Relations
Northwest Bio?therapeutics, Inc.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News